US3906950A - Inhaling device for powdered medicaments - Google Patents
Inhaling device for powdered medicaments Download PDFInfo
- Publication number
- US3906950A US3906950A US457270A US45727074A US3906950A US 3906950 A US3906950 A US 3906950A US 457270 A US457270 A US 457270A US 45727074 A US45727074 A US 45727074A US 3906950 A US3906950 A US 3906950A
- Authority
- US
- United States
- Prior art keywords
- inhaler
- pair
- pump
- piece
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Definitions
- the base element of the inhaler is so shaped that when the device is not in use, the inhaler body may be inverted into the pump, therby resulting in a noticeable reduction in overall size and a pleasant compact aspect of the whole which is aesthetically and practically favorable.
- An inhalingdeyice for-delivering powderedsubstances in aerated form from a pierced capsule, comprisinga pumpand. an inhaler, said inhalercomprising:
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
An inhaling device for medicinal powders comprising a pump and an inhaler wherein the inhaler has a cavity formed by the interconnection of two compartments for holding a puncturable capsule containing a medicinal powder. Two sliding needles acting against the action of return springs pierce the capsule. In a preferred embodiment, the lower body portion of the inhaler is attached to the pump when in use and may be stored in ''''at rest'''' position when the inhaler is inverted into the pump.
Description
tinited States @ocozza 1 INHALING DEVICE FOR POWDERED MEDICAMENTS [75] lnventor: Salvatore Cocozza, Milan, Italy [73} Assignee: I.S.F. S.p.A., Milan, ltaly [22] Filed: Apr. 2, 1974 [21] Appl. No.: 457,270
[30] Foreign Application Priority Data Apr. 4, 1973 Italy 22576/73 June 22, 1973 Italy; 25698/73 [52] US. Cl. 128/266; 128/206 [51] Int. Cl. A61M 13/00; A61M 15/08 [58] Field of Search 128/266, 206, 208, 194, 128/265 [56] References Cited UNITED STATES PATENTS 2,307,986 l/1943 Bolt et al. 128/266 so ,2 20* y 2,517,482 8/1950 Hall 128/206 2,519,555 8/1950 128/266 2,581,182 l/1952 128/206 2,946,332 7/1960 Sacks 128/266 3507277 4/1970 Altounyan et al 128/208 3,669,113 6/1972 Altounyan et a1. 128/266 Primary Examiner-Aldrich F. Medbery Attorney, Agent, or Firm-Depaoli & OBrien [57] ABSTRACT An inhaling device for medicinal powders comprising a pump and an inhaler wherein the inhaler has a cavity formed by the interconnection of two-compartments for holding a puncturable capsule containing a medici nal powder. Two sliding needles acting against the action of return springs pierce the capsule. In a preferred embodiment, the lower body portion of the inhaler is attached to the pump when in use and may be stored in at rest position when the inhaler is inverted into the pump.
22 Claims, 6 Drawing Figures r L 56o US Patent Sept. 23,1975 Sh6t 1 01 2 3,906,950
US mm Sept. 23,1975 Sheet 2' 0f 2 3,9,%
INHALING DEVICE FOR POWDERED MEDICAMENTS BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to an inhaler for the administration of medicinal powders. More particularly, the inhaler relates to a traditional pump and an inhaler body having means for piercing a stored capsule containing medicinal powder.
2. Description of the Prior Art Inhalers are already known utilizing an elastic pump and a needle piercing a capsule which contains a me' dicinal substance; generally their working is not completely satisfactory as a result of rather complicated construction and cumbersome dimensions. In the in haler of the present invention, the above mentioned inconveniences have been practically eliminated, so that the inhaler is easily and quickly constructed and of reduced dimensions.
SUMMARY OF THE INVENTION It is the object of this invention to providean inhaler having simplified construction and reduced dimensions for use in combination with a conventional pump as an inhaling device for supplying medicinal powders to a body cavity.
It is another object to provide an inhaler having means for partial storage within the pump therefor.
It is an additional object to provide an inhaler having a means wheel to facilitate locking engagement with the pump.
It is a further object to provide an inhaler having a plurality of slidable alignment means. I
It is also an object to provide an inhaler having a spring-biased means for penetrating each end of a capsule stored therewithin.
In satisfaction of these objects and in accordance with the spirit of this invention, the inhaler contains a cavity-penetrating element. at one end thereof, through which air-entrained powder is forced out into a body cavity. a central element with an inside cavity for locating a capsule of medicinal powder therewithin. a pair of piercing devices for the endwise perforation of the capsule, and a base element having a polished surface interrupted by a ratchet wheel for connection with the pump. In more detail, the central element ofthe inhaler body is relatively fixed and formed by two components which are connected to each other, for example, by threading, bayonet insertion, and similar techniques. These components define a cavity therewithin, for placement of the capsule, and are slidably attached to a pair of relatively movable elements which hold piercing needles and which telescopically slide inside the two above-mentioned capsule holder components against the action of a pair of return springs.
The base element of the inhaler is so shaped that when the device is not in use, the inhaler body may be inverted into the pump, therby resulting in a noticeable reduction in overall size and a pleasant compact aspect of the whole which is aesthetically and practically favorable.
The inhaling device is adapted for delivering powdered substances in aerated form from a pierced capsule and comprises a pump and an inhaler, the inhaler comprising a relatively fixed central element formed by two connectable components and defining a cavity for reception of the capsule. and a pair of relatively moveable needle holder elements telescopically slidablc within the connectable components against the action of a pair of return springs. The components may be connected by screw means, a bayonet clutch means. or the like. Each of the pair of needle holder elements comprises a capsule-piercing needle. Each of the components is attached to a sleeve having an interior shoulder and each of the pair of needle holder elements has an outwardly disposed shoulder which is capable of reciprocating between a rest position against one of the interior shoulders and a ncedle-piercing position against one of the connectable components. The inhaler also comprises a nose piece and a pump piece and one of the pair of holder elements is locked by friction to the noscpiecc and the other of the pair of needle holder elements may be locked against the piece by mi cro-ribs having saw teeth.
BRIEF DESCRIPTION OF THE DRAWINGS The inhaler which constitutes the present invention is shown in the accompanying drawings of the preferred embodiment in which:
FIG. 1 represents a side elevation of the assembled inhaling device comprising the inhaler inserted in a pump in operative condition.
FIG. 2 is a side elevation similar to FIG. I with the inhaler inverted in the pump to reduce the size of the device while partially stored therewithin.
FIG. 3 is a longitudinal section through the inhaler while in uncompressed condition.
FIG. 4 is a longitudinal section of the inhaler. similar to FIG. 3 but with the inhaler in a compressed condition, while in operative combination with a pump.
FIG. 5 is a cross-section taken along lines 55 of FIG. 3, and
FIG. 6 is a side elevation of the noseward component of the cavity-forming element.
DESCRIPTION OF THE PREFERRED EMBODIMENT Referring to the drawings. the inhaler 8 of this invention is employed in combination with a conventional pump 100 and comprises a central storage unit 10 having a central cavity defined by walls 13 within which a medicinal powder-container capsule 15 is inserted as needed by unscrewing a pair of compartments 20, 30. A pair of stop sleeves 60, 70 are non-slidably attached to the unit 10 and are outside of and in sliding relation to a pair of needle holders 40, containing a pair of capsule-puncturing needles 41, 51. The pair of stop sleeves 60, is also within and in sliding relation to a pair of end pieces, the nose piece and the pump piece 90, to which the holders 40, 50 are rigidly attached. The holders 40, 50 are biased away from the central cavity by a pair of springs 25, 35.
Coaxially disposed throughout the entire inhaler of this invention are a series of central holes for passage of air which enters the inhaler from the pump through base opening 98 and air passage 58, passes through the four air passages 59 shown in FIG. 5 to central hole 32 around pump needle 51, enters and passes through the punctured capsule 15 while entraining medicinal powder therefrom. travels past nose needle 41 through central hole 22, passes through the four air passages 49 into swirl compartment 83, and exits from the inhaler through discharge hole 81 in nosepiece 80.
The unit is formed by screwably connecting the nose compartment and the base compartment 30. The compartments 20, have coaxially disposed central holes 22, 32, annularly disposed spring wells 24, 34 which open away from the capsule 15, outer cylindrical recesses with surfaces 23, 33, and connecting screw threads 29, 39 by means of which the compartments 20, 30 are connected. Nose return spring 25 is seated within spring well 24, and pump return spring is seated within spring well 34.
Additionally, the holders 40, 50 respectively comprise circumannular shoulders 45, 55 which extend outwardly exactly as far as the walls 23, 33 of the sleeve recesses of each compartment 20, 30. The circular sides 48, 58 of the shoulders 45, 55, opposite to the cavity for the capsule 15, function as a stop means in cooperation with the nose sleeve 60 and the pump sleeve 70, respectively, and the outer cylindrical surfaces of the shoulders 45, 55 are in sliding contact with the inner cylindrical surfaces 61, 71 of the sleeves 60, 70, thus functioning cooperatively therewith as an alignment means.
The nose and pump sleeve 60, respectively comprise elongated cylindrical portions, having outer sides 62, 72 and inner sides 61, 71, and inwardly extending interior shoulders 65, 75, having respective cavityfacing circular surfaces 66, 76, inner cylindrical surfaces 68, 78, and endward-facing circular surfaces 67, 77. The surfaces 68, 78 function as a sliding alignment means in cooperation with the cylindrical surfaces 46a, 56a of the fixed ends 46, 56 of the needle holders 40, 50. The inner side 61, 71 are non-slidably attached to the recessed outer surfaces 23, 33 and function cooperatively with the cylindrical outer surfaces of the shoulders 45, 55 as another sliding alignment means. Nonslidable attachment may be attained by means of suitable adhesive or by circumferential knurlings of the facing surfaces such as the knurlings 26 which are indicated in FIG. 6.
The nose piece 80 comprises a tapered penetration portion 82 through which passes the central discharge hole 81 therein. a skirt portion 84 which extends toward the cavity 15, and a stepped portion 85 therebetween. An annular recess coincides with the inner edge of the step portion 85 and penetrates longitudinally into the penetration portion 82. Into this annular recess, the fixed end 46 of the nose needle holder 40 is rigidly attached. as with an adhesive. The outer surface 62 of the nose sleeve 60 is in sliding engagement with the inner surface of the skirt 84 and functions cooperatively therewith as an alignment means.
The pump piece comprises an outer rim 91, a base 92 having an inwardly projecting circular lip to define the base opening 98, a circular lug 94 spaced pumpward from the edge of the rim 91, and circumferential serrations 97 along the inner surface of the base 92 and noseward of its circular lip. The lug 94 has a circular and arcuately receding surface 95, which acts as a storage stop means when the inhaler is in its inverted storage position shown in FIG. 2, and a circular and radially extending surface 96 which acts as an operational stop means when the inhaler is inserted into a conventional pump 100, as shown in FIGS. 1, 3, and 4. The serrations 97, which may be considered as ribbings, corrugations, or knurlings, are matched and engaged by similar serrations in the surfaces 56a.
The pump 100 typically has side walls 101, a circular top edge 102 which engages the surface 96 when the inhaler 8 is in operative position, and an air-containing interior 104 which should have sufficient depth to accommodate the inhaler 8 from the surface to the tip of the penetration portion 82 when the inhaler 8 is in stored position partially within the pump 100.
In summary, the inhaler 8 comprises three pairs of slidable alignment means:
I. inner cylindrical surfaces of skirt 84 and rim 91 in sliding contact with outer cylindrical surfaces 62, 72; 2. inner cylindrical surfaces 61, 71 in sliding contact with outer cylindrical surfaces of the shoulders 45, 55; and 3. inner cylindrical surfaces 68, 78 in sliding contact with outer cylindrical surfaces 46:1, 560. Because of these three pairs of slidable alignment means, the inhaler 8 possesses a high degree of trueness so that binding and wear are minimized.
In FIGS. 1-4, the profile of the cylindrical surface of the lower body portion of the inhaler 8, which is connected by friction with a pump of suitable dimensions and configuration, is polished and uniform and interrupted by the lug 94 where circular lines of contact 95 and 96 with the cylindrical surface represent the stop points in locking engagement with the pump 100 when the inhaler 8 is ready to use and when it is in storage position, respectively.
The inhaling device operates as follows:
Initially, the inhaler 8, inverted in the pump 100 (as shown in FIG. 2 is extracted therefrom and connected by friction locking in its upright position to the pump 100. Compartment 20 is then screwed off from compartment 30 and the capsule 15 of powder is inserted therein, after which nosepiece 80 and pumppiece 90 are moved towards one another, i.e., a contraction of the inhaler is caused along arrows AB, which creates two diametrally opposed perforations in capsule 15. Compare FIG. 1 with FIG. 4. Thereafter, it is possible to press the pump 100 to provoke the passage of the powder content of the capsule into a human cavity, such as nasal cavity or other cavities of the human body.
The present invention is not to be limited to the specific embodiment having the scope and advantages described hereinbefore, for various modifications can be made without departing from the spirit of the invention which should he understood asbeihglimited onlyiby the scope of the accompanying"claimst a 1. An inhalingdeyice, for-delivering powderedsubstances in aerated form from a pierced capsule, comprisinga pumpand. an inhaler, said inhalercomprising:
A. a, relatively fixed central element formed by two connectahle components and def ini ng a cavity. for reception of said capsule, and
B. a pair of relatively movcable ncc dleiholde'r ielm ments including piercing means mounted therein, which are: i IN 4 i r H l. telescopically slidable within said'corinectable components against the action of a pair of return springs and in the path of movement of air through said inhaler,
2. disposed in mutually opposed relationship and in straddling relationship to said capsule, and
3. constituting a means for piercing said capsule when said springs are compressed by slidably moving said needle holder elements toward each other.
2. The inhaling device of claim 1 whereinsaid components are connected by screw means.
3. The inhaling device of claim 1 wherein each of said pair of needle holer elements comprises a capsulepiercing needle.
4. The inhaling device of claim 1 wherein each of said components is attached to a sleeve having an interior shoulder and each of said pair of needle holder elements has an outwardly disposed shoulder which is capable of reciprocating between a rest position against one of said interior shoulders and a needle-piercing position against one of said conncctable components.
5. The inhaling device of claim 4 wherein said inhaler comprises a nose piece and a pump piece and one of said pair of said needle holder elements is locked by friction to said nose piece and the other of said pair of needle holder elements is locked against said pump piece by micro-ribs having saw teeth.
6. An inhaler for storing, entraining, and delivering powders in aerated condition, comprising;
A. a central storage unit for said powders,
B. a pair of needle holders including piercing means mounted therein which straddle said unit and are slidably connected thereto,
C. a nose piece which is non-slidably attached to one of said pair of needle holders,
D. a pump piece which is non-slidably attached to the other of said pair of needle holders, and
E. a longitudinally disposed air passage means extending from end to end of said inhaler, through said pump piece, said pair of needle holders, said central storage unit, and said nose piece, said nose piece and said pump piece ecah being longitudinally slidable toward said central storage unit to provide opposed piercing means for the central storage unit, whereby said powders are released.
7. The inhaler of claim 6 wherein said central storage unit comprises a pair of connectable compartments which define and contain. in combination, a cavity thcrewithin for storage of a capsule containing said powder.
8. The inhaler of claim 7 wherein each of said pair of conncctable compartments comprises an annular spring well within which a compression spring is seated.
'9. T he inhaler of claim.8 wherein each of said pair of needle holderscomprises a annular sliding end which is;slidably mounted within one of said annular spring wells andinengagement-with one .Of said springs.
10. The inhaler of claim 9.which further comprises a pair of stop:slceves which straddle said. unit and are non-slidably attached thereto.
11:. The inhaler of claim 10 wherein said pair of stop sleeves is in slidably circumferential and alignmentma'intaining relation to said pair of needle holder element's. 1 I
"12.The inhaler of claim 11- wherein each of said pair of stop sleeves has a cylindrical inner wall and said needle holders comprise circumanntilar shoulders which extend outwardly into slidable and alignmentmaintaining relation with said cylindrical inner walls of said stop sleeves.
13. The inhaler of claim 12 wherein each of said pair of needle holders additionally comprises an annular fixed end, one of said fixed ends being non-slidably attached to said nose piece and the other being nonslidably attached to said pump piece.
14. The inhaler of claim 13 wherein each of said pair of needle holders comprises a capsule-piercing needle, said needles being coaxially disposed in mutually opposed relationship and in straddling relationship to said capsule and being adapted to pierce said capsule when said springs are compressed by slidably moving said nose piece and said pump piece toward each other.
15. The inhaler of claim 14 wherein each of said stop sleeves additionally comprises an inwardly extending interior shoulder which extends into sliding engagement with exterior cylindrical surfaces of said fixed ends, as a sliding alignment means.
16. The inhaler of claim 15 wherein:
A. said nosepiece, said stop sleeves, and said central storage unit have a smaller exterior diameter than the exterior diameter of said pump piece, and
B. said pump piece comprises a circumferential and outwardly extending lug having an arcuately recedingsurface and a radially receding surface,
whereby said arcuately receding surface functions as a storage stop means, when said inhaler is inverted into a pump for storage by inserting said nose piece thereinto, and said radially receding surface functions as an operational stop means, when said inhaler is inserted into said pump by engaging said pump piece therewith.
17. The inhaler of claim 16 wherein said pump piece further has an exterior cylindrical surface which is polished and uniformly interrupted by a friction locking means for the mouthpiece of said pump.
18. The inhaling device of claim 17 wherein the points of contact between the cylindrical surface of the lower body portion and the surface normal to said means are friction locking points between said inhaler and said pump.
19. The inhaling device of claim 17 wherein the points of contact between the cylindrical surface of the lower body portion and the portions of said means have curved surfaces which are stop points for friction locking between said inhaler and said pump when said inhaling device is not in use.
20. The inhaling device of claim 5 wherein:
A. said nose piece and said. pump piece each comprises a skirt portion extending toward said cavity and having an inner cylindrical surface adapted for sliding contact; and
B. each said sleeve comprises an outer cylindrical surface adapted for said sliding contact with one of said inner cylindrical surfaces of said skirt portions of said nose piece and said pump piece to form a first pair of slidable alignment means.
21. The inhaling device of claim wherein:
Apeach said sleeve, attached to one of said two conncctahle components. comprises an inner cylindrical surface adapted for sliding contact; and
B. each said outwardly disposed shoulder of said pair of needle holder elements comprises an outer cylindrical surface adapted for said sliding contact with one of said sleeves to form a second pair of slidable alignment means.
22. The inhaling device of claim 21 wherein:
A. each said interior shoulder of said sleeves attached to said two components comprises an inner cylindrical surface adapted for sliding contact: and
Bi each said needle holder element comprises an outer cylindrical surface adapted for said sliding contact with one of said inner cylindrical surfaces of said interior shoulders to form a third slidable alignment means. said first, second. and third pairs of slidable alignment means imparting a high degree of trueness to said inhaler so that binding and wear are minimized.
Claims (24)
1. An inhaling device, for delivering powdered substances in aerated form from a pierced capsule, comprising a pump and an inhaler, said inhaler comprising: A. a relatively fixed central element formed by two connectable components and defining a cavity for reception of said capsule, and B. a pair of relatively moveable needle holder elements including piercing means mounted therein, which are: 1. telescopically slidable within said connectable components against the action of a pair of return springs and in the path of movement of air through said inhaler, 2. disposed in mutually opposed relationship and in straddling relationship to said capsule, and 3. constituting a means for piercing said capsule when said springs are compressed by slidably moving said needle holder elements toward each other.
2. disposed in mutually opposed relationship and in straddling relationship to said capsule, and
2. The inhaling device of claim 1 wherein said components are connected by screw means.
3. constituting a means for piercing said capsule when said springs are compressed by slidably moving said needle holder elements toward each other.
3. The inhaling device of claim 1 wherein each of said pair of needle holer elements comprises a capsule-piercing needle.
4. The inhaling device of claim 1 wherein each of said components is attached to a sleeve having an interior shoulder and each of said pair of needle holder elements has an outwardly disposed shoulder which is capable of reciprocating between a rest position against one of said interior shoulders and a needle-piercing position against one of said connectable components.
5. The inhaling device of claim 4 wherein said inhaler comprises a nose piece and a pump piece and one of said pair of said needle holder elements is locked by friction to said nose piece and the other of said pair of needle holder elements is locked against said pump piece by micro-ribs having saw teeth.
6. An inhaler for storing, entraining, and delivering powders in aerated condition, comprising; A. a central storage unit for said powders, B. a apir of needle holders including piercing means mounted therein which straddle said unit and are slidably connected thereto, C. a nose piece which is non-slidably attached to one of said pair of needle holders, D. a pump piece which is non-slidably attached to the other of said pair of needle holders, and E. a longitudinally disposed air passage means extending from end to end of said inhaler, through said pump piece, said pair of needle holders, said central storage unit, and said nose piece, said nose piece and said pump piece ecah being longitudinally slidable toward said central storage unit to provide opposed piercing means for the central storage unit, whereby said powders are released.
7. The inhaler of claim 6 wherein said central storage unit comprises a pair of connectable compartments which define and contain, in combination, a cavity therewithin for storage of a capsule containing said powder.
8. The inhaler of claim 7 wherein each of said pair of connectable compartments comprises an annular spring well within which a compression spring is seated.
9. The inhaler of claim 8 wherein each of said pair of needle holders comprises a annular sliding end which is slidably mounted within one of said annular spring wells and in engagement with one of said springs.
10. The inhaler of claim 9 which further comprises a pair of stop sleeves which straddle said unit and are non-slidably attached thereto.
11. The inhaler of claim 10 wherein said pair of stop sleeves is in slidably circumferential and alignment-maintaining relation to said pair of needle holder elements.
12. The inhaler of claim 11 wherein each of said pair of stop sleeves has a cylindrical inner wall and said needle holders comprise circumannular shoulders which extend outwardly into slidable and alignment-maintaining relation with said cylindrical inner walls of said stop sleeves.
13. The inhaler of claim 12 wherein each of said pair of needle holders additionally comprises an annular fixed end, one of said fixed ends being non-slidably attached to said nose piece and the other being non-slidably attached to said pump piece.
14. The inhaler of claim 13 wherein each of said pair of needle holders comprises a capsule-piercing needle, said needles being coaxially disposed in mutually opposed relationship and in straddling relationship to said capsule and being adapted to pierce said capsule when said springs are compressed by slidably moving said nose piece and said pump piece toward each other.
15. The inhaler of claim 14 wherein each of said stop sleeves additionally comprises an inwardly extending interior shoulder which extends into sliding engagement with exterior cylindrical surfaces of said fixed ends, as a sliding alignment means.
16. The inhaler of claim 15 wherein: A. said nosepiece, said stop sleeves, and said central storage unit have a smaller exterior diameter than the exterior diameter of said pump piece, and B. said pump piece comprises a circumferential and outwardly extending lug having an arcuately receding surface and a radially receding surface, whereby said arcuately receding surface functions as a storage stop means, when said inhaler is inverted into a pump for storage by inserting said nose piece thereinto, and said radially receding surface functions as an operational stop means, when said inhaler is inserted into said pump by engaging said pump piece therewith.
17. The inhaler of claim 16 wherein said pump piece further has an exterior cylindrical surface which is polished and uniformly interrupted by a friction locking means for the mouthpiece of said pump.
18. The inhaling device of claim 17 wherein the points of contacT between the cylindrical surface of the lower body portion and the surface normal to said means are friction locking points between said inhaler and said pump.
19. The inhaling device of claim 17 wherein the points of contact between the cylindrical surface of the lower body portion and the portions of said means have curved surfaces which are stop points for friction locking between said inhaler and said pump when said inhaling device is not in use.
20. The inhaling device of claim 5 wherein: A. said nose piece and said pump piece each comprises a skirt portion extending toward said cavity and having an inner cylindrical surface adapted for sliding contact; and B. each said sleeve comprises an outer cylindrical surface adapted for said sliding contact with one of said inner cylindrical surfaces of said skirt portions of said nose piece and said pump piece to form a first pair of slidable alignment means.
21. The inhaling device of claim 20 wherein: A. each said sleeve, attached to one of said two connectable components, comprises an inner cylindrical surface adapted for sliding contact; and B. each said outwardly disposed shoulder of said pair of needle holder elements comprises an outer cylindrical surface adapted for said sliding contact with one of said sleeves to form a second pair of slidable alignment means.
22. The inhaling device of claim 21 wherein: A. each said interior shoulder of said sleeves attached to said two components comprises an inner cylindrical surface adapted for sliding contact; and B. each said needle holder element comprises an outer cylindrical surface adapted for said sliding contact with one of said inner cylindrical surfaces of said interior shoulders to form a third slidable alignment means, said first, second, and third pairs of slidable alignment means imparting a high degree of trueness to said inhaler so that binding and wear are minimized.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2257673A IT986056B (en) | 1973-04-04 | 1973-04-04 | INSUFFLATOR FOR POWDER-SHAPED MEDICATIONS |
IT2569873A IT1045851B (en) | 1973-06-22 | 1973-06-22 | Inhaler for administering powdered medicaments - offers long term trouble free efficiency from particularly simple, inexpensive construction |
Publications (1)
Publication Number | Publication Date |
---|---|
US3906950A true US3906950A (en) | 1975-09-23 |
Family
ID=26328226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US457270A Expired - Lifetime US3906950A (en) | 1973-04-04 | 1974-04-02 | Inhaling device for powdered medicaments |
Country Status (7)
Country | Link |
---|---|
US (1) | US3906950A (en) |
JP (1) | JPS5048782A (en) |
BE (1) | BE813143A (en) |
CH (1) | CH569486A5 (en) |
DE (2) | DE7411543U (en) |
FR (1) | FR2224175B1 (en) |
GB (1) | GB1436813A (en) |
Cited By (210)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4013075A (en) * | 1974-07-15 | 1977-03-22 | I.S.F. S.P.A. | Inhalers and insufflators having a cutting means |
US4069819A (en) * | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
US4095596A (en) * | 1976-11-26 | 1978-06-20 | Smithkline Corporation | Nasal inhaler |
US4105027A (en) * | 1975-06-13 | 1978-08-08 | Syntex Puerto Rico, Inc. | Inhalation device |
US4116195A (en) * | 1976-02-10 | 1978-09-26 | Allen & Hanburys Limited | Device for dispensing medicaments |
US4240418A (en) * | 1974-08-22 | 1980-12-23 | Schering Aktiengesellschaft | Apparatus for the inhalation of medicinal agents |
US4338931A (en) * | 1979-04-27 | 1982-07-13 | Claudio Cavazza | Device for the quick inhalation of drugs in powder form by humans suffering from asthma |
US4446862A (en) * | 1979-10-30 | 1984-05-08 | Baum Eric A | Breath actuated devices for administering powdered medicaments |
US4620847A (en) * | 1984-06-01 | 1986-11-04 | Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov | Device for administering powdered substances |
US4645487A (en) * | 1984-06-05 | 1987-02-24 | Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov | Device for administering powdered substances |
US4884565A (en) * | 1987-08-17 | 1989-12-05 | Miat S.P.A. | Insufflator for the administration of drugs in the form of a powder pre-dosed into opercola |
US4889114A (en) * | 1983-12-17 | 1989-12-26 | Boehringer Ingelheim Kg | Powdered pharmaceutical inhaler |
US5033463A (en) * | 1989-10-27 | 1991-07-23 | Miat S.P.A. | Multi-dose inhaler for medicaments in powder form |
US5152284A (en) * | 1989-02-23 | 1992-10-06 | Phidea S.P.A. | Disposable inhaler with pre-pierced capsule |
US5161524A (en) * | 1991-08-02 | 1992-11-10 | Glaxo Inc. | Dosage inhalator with air flow velocity regulating means |
US5366122A (en) * | 1991-08-27 | 1994-11-22 | Ing. Erich Pfeiffer Gmbh & Co. Kg | Dispenser for flowable media |
US5388573A (en) * | 1993-12-02 | 1995-02-14 | Tenax Corporation | Dry powder inhalator medicament carrier |
US5388572A (en) * | 1993-10-26 | 1995-02-14 | Tenax Corporation (A Connecticut Corp.) | Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same |
US5460173A (en) * | 1993-03-03 | 1995-10-24 | Tenax Corporation | Dry powder inhaler medicament carrier |
US5488946A (en) * | 1994-03-01 | 1996-02-06 | Calhoun; Clifford A. | Emergency breathing device for opening cartridges |
WO1996012513A1 (en) * | 1994-10-24 | 1996-05-02 | Oxford Biosciences Limited | Particle delivery |
EP0761248A1 (en) * | 1995-03-10 | 1997-03-12 | Unisia Jecs Corporation | Intranasal medicator |
US5617845A (en) * | 1990-08-30 | 1997-04-08 | Boehringer Ingelheim Kg | Inhalation device free from propellent gas |
US5692496A (en) * | 1995-08-02 | 1997-12-02 | Innovative Devices, Llc | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
US5715811A (en) * | 1994-05-26 | 1998-02-10 | Unisia Jecs Corporation | Inhaling type medicine administering device and using method therefor |
US5752505A (en) * | 1996-03-21 | 1998-05-19 | Unisia Jecs Corporation | Inhalation-type medicine delivery device |
US5810004A (en) * | 1995-10-09 | 1998-09-22 | Unisia Jecs Corporation | Medicator for a capsule filled with a powdered drug |
US5823183A (en) * | 1995-08-02 | 1998-10-20 | Innovative Devices | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
WO1998058695A1 (en) * | 1997-06-23 | 1998-12-30 | Marco Cecchini | Inhaling device |
US5901703A (en) * | 1995-02-06 | 1999-05-11 | Unisia Jecs Corporation | Medicine administering device for nasal cavities |
US5988163A (en) * | 1995-08-02 | 1999-11-23 | Innovative Devices | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament |
US6013050A (en) * | 1995-10-20 | 2000-01-11 | Powderject Research Limited | Particle delivery |
US6048857A (en) * | 1989-10-17 | 2000-04-11 | Ellinwood, Jr.; Everett H. | Dosing method of administering medicaments via inhalation administration |
US6186141B1 (en) * | 1996-05-10 | 2001-02-13 | Glaxo Wellcome Inc. | Unit dose dispensing device |
US6209538B1 (en) * | 1995-08-02 | 2001-04-03 | Robert A. Casper | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
US6273086B1 (en) * | 1998-02-06 | 2001-08-14 | Unisia Jecs Corporation | Inhalant medicator |
US20010029947A1 (en) * | 1999-12-17 | 2001-10-18 | Steve Paboojian | Receptacles to facilitate the extraction of powders |
US6341605B1 (en) * | 1998-02-05 | 2002-01-29 | Unisia Jecs Corporation | Inhalant medicator |
US20020134382A1 (en) * | 2000-05-10 | 2002-09-26 | Snow John M. | Medicament container with same side airflow inlet and outlet and method of use |
US6546929B2 (en) | 1998-06-04 | 2003-04-15 | Inhale Therapeutic Systems, Inc. | Dry powder dispersing apparatus and methods for their use |
US20030131847A1 (en) * | 2002-01-16 | 2003-07-17 | Fabrizio Niccolai | Device usable in the treatment of affections of the airways |
US20030150454A1 (en) * | 2001-11-14 | 2003-08-14 | Inhale Therapeutic Systems, Inc. | Aerosolization apparatus with removable mouthpiece |
EP1108439A3 (en) * | 1999-12-15 | 2003-09-10 | Ing. Erich Pfeiffer GmbH | Product dispenser |
US6681768B2 (en) | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
US20040077528A1 (en) * | 1999-06-29 | 2004-04-22 | Mannkind Corporation | Purification and stabilization of peptide and protein pharmaceutical agents |
US6732732B2 (en) | 2001-04-16 | 2004-05-11 | Advanced Inhalation Research, Inc. | Inhalation device and method |
US20040096403A1 (en) * | 1995-05-15 | 2004-05-20 | Mannkind Corporation | Method for drug delivery to the pulmonary system |
US20040182387A1 (en) * | 1999-07-23 | 2004-09-23 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US20040206350A1 (en) * | 2002-12-19 | 2004-10-21 | Nektar Therapeutics | Aerosolization apparatus with non-circular aerosolization chamber |
US20050028813A1 (en) * | 2001-10-05 | 2005-02-10 | Ian Harrison | Apparatus for the nasal or oral delivery of a medicament |
US20050088617A1 (en) * | 2003-10-27 | 2005-04-28 | Jen-Chuen Hsieh | Method and apparatus for visual drive control |
US20050150492A1 (en) * | 2003-04-09 | 2005-07-14 | Nektar Therapeutics | Aerosolization apparatus with air inlet shield |
US20050153874A1 (en) * | 2004-01-12 | 2005-07-14 | Mannkind Corporation | Method of reducing serum proinsulin levels in type 2 diabetics |
US20050177095A1 (en) * | 2002-05-14 | 2005-08-11 | Tatsuo Tsutsui | Powder chemical feeding device for nasal cavity |
US20050186146A1 (en) * | 2004-02-12 | 2005-08-25 | Nektar Therapeutics | Interleukin-13 antagonist powders, spray-dried particles, and methods |
US20050250705A1 (en) * | 2004-05-10 | 2005-11-10 | Boehringer Ingelheim Pharma Gmbh Co. Kg | Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation |
US20050250704A1 (en) * | 2004-05-10 | 2005-11-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder comprising new compositions of oligosaccharides and methods for their preparation |
US20050255119A1 (en) * | 2004-05-10 | 2005-11-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives |
US6978941B2 (en) | 2001-05-02 | 2005-12-27 | Aerogen, Inc. | Base isolated nebulizing device and methods |
US7032593B2 (en) | 2000-08-14 | 2006-04-25 | Advanced Inhalation Research, Inc. | Inhalation device and method |
US7032590B2 (en) | 2001-03-20 | 2006-04-25 | Aerogen, Inc. | Fluid filled ampoules and methods for their use in aerosolizers |
US7040549B2 (en) | 1991-04-24 | 2006-05-09 | Aerogen, Inc. | Systems and methods for controlling fluid feed to an aerosol generator |
WO2006051300A1 (en) | 2004-11-10 | 2006-05-18 | Cipla Limited | Inhaler |
US7066398B2 (en) | 1999-09-09 | 2006-06-27 | Aerogen, Inc. | Aperture plate and methods for its construction and use |
US7112341B1 (en) | 1999-04-13 | 2006-09-26 | Nektar Therapeutics | Pulmonary administration of dry powder formulations for treating infertility |
US20070020191A1 (en) * | 1999-06-29 | 2007-01-25 | Mannkind Corporation | Potentiation of glucose elimination |
US7174888B2 (en) | 1995-04-05 | 2007-02-13 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US20070051362A1 (en) * | 2004-04-23 | 2007-03-08 | Sullivan Timothy R | Multiple unit dose drug delivery system |
US7195011B2 (en) | 2001-03-20 | 2007-03-27 | Aerogen, Inc. | Convertible fluid feed system with comformable reservoir and methods |
US7201167B2 (en) | 2004-04-20 | 2007-04-10 | Aerogen, Inc. | Method and composition for the treatment of lung surfactant deficiency or dysfunction |
US20070086952A1 (en) * | 2005-09-29 | 2007-04-19 | Biodel, Inc. | Rapid Acting and Prolonged Acting Inhalable Insulin Preparations |
WO2007098870A1 (en) * | 2006-02-24 | 2007-09-07 | Aha Kunststofftechnik Gmbh | Dry powder inhaler |
US20070209659A1 (en) * | 1995-04-05 | 2007-09-13 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US7290541B2 (en) | 2004-04-20 | 2007-11-06 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
US20070283955A1 (en) * | 2006-06-07 | 2007-12-13 | Bioactis Limites | Peroral powder delivery device |
US7322349B2 (en) | 2000-05-05 | 2008-01-29 | Aerogen, Inc. | Apparatus and methods for the delivery of medicaments to the respiratory system |
US20080039368A1 (en) * | 2006-04-12 | 2008-02-14 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
US7331339B2 (en) | 2000-05-05 | 2008-02-19 | Aerogen, Inc. | Methods and systems for operating an aerosol generator |
US20080053437A1 (en) * | 1999-07-23 | 2008-03-06 | Mannkind Corporation | Unit dose capsules and dry powder inhaler |
US20080063606A1 (en) * | 2001-12-19 | 2008-03-13 | Tarara Thomas E | Pulmonary delivery of aminoglycoside |
US20080090753A1 (en) * | 2004-03-12 | 2008-04-17 | Biodel, Inc. | Rapid Acting Injectable Insulin Compositions |
US7360536B2 (en) | 2002-01-07 | 2008-04-22 | Aerogen, Inc. | Devices and methods for nebulizing fluids for inhalation |
US20080177246A1 (en) * | 2007-01-09 | 2008-07-24 | First City Tower | Intranasal Cartridge Devices |
US20080248999A1 (en) * | 2007-04-04 | 2008-10-09 | Biodel Inc. | Amylin formulations |
US20090025721A1 (en) * | 2007-06-12 | 2009-01-29 | Alkermes, Inc. | Powder inhaler devices |
US20090071108A1 (en) * | 2007-09-14 | 2009-03-19 | Mystic Pharmaceuticals, Inc. | Deep draw container forming method |
US20090090433A1 (en) * | 2005-05-18 | 2009-04-09 | Symyx Technologies Europe Sa | Apparatus And Method For Storing And Dispensing Material, Especially In Micro Quantities And In Combination With Limited Starting Amounts |
US20090117193A1 (en) * | 1999-10-29 | 2009-05-07 | Nektar Therapeutics | Compositions Comprising an Active Agent |
US20090137455A1 (en) * | 2005-09-29 | 2009-05-28 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
US20090175840A1 (en) * | 2008-01-04 | 2009-07-09 | Biodel, Inc. | Insulin formulations for insulin release as a function of tissue glucose levels |
US20090194105A1 (en) * | 2006-04-13 | 2009-08-06 | Jens Besseler | Inhaler |
US20090241949A1 (en) * | 2008-03-27 | 2009-10-01 | Smutney Chad C | Dry powder inhalation system |
US7600511B2 (en) | 2001-11-01 | 2009-10-13 | Novartis Pharma Ag | Apparatus and methods for delivery of medicament to a respiratory system |
US7628339B2 (en) | 1991-04-24 | 2009-12-08 | Novartis Pharma Ag | Systems and methods for controlling fluid feed to an aerosol generator |
US20090320838A1 (en) * | 2006-06-16 | 2009-12-31 | Cipla Limited | Dry powder inhaler |
US7669597B2 (en) | 2007-05-16 | 2010-03-02 | Mystic Pharmaceuticals, Inc. | Combination unit dose dispensing containers |
US7677467B2 (en) | 2002-01-07 | 2010-03-16 | Novartis Pharma Ag | Methods and devices for aerosolizing medicament |
US7713929B2 (en) | 2006-04-12 | 2010-05-11 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
US7771642B2 (en) | 2002-05-20 | 2010-08-10 | Novartis Ag | Methods of making an apparatus for providing aerosol for medical treatment |
US20100287884A1 (en) * | 2007-10-25 | 2010-11-18 | Sangita Seshadri | Powder conditioning of unit dose drug packages |
US20100288275A1 (en) * | 2007-04-05 | 2010-11-18 | Optinose As | Nasal administration |
US20100313886A1 (en) * | 2007-08-01 | 2010-12-16 | Herbert Wachtel | Inhaler |
US20110033544A1 (en) * | 2009-05-15 | 2011-02-10 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal pharmaceutical compositions with improved pharmacokinetcs |
US20110045088A1 (en) * | 2009-07-31 | 2011-02-24 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
US20110056488A1 (en) * | 2008-01-24 | 2011-03-10 | Vectura Delivery Devices Limited | Inhaler |
US7946291B2 (en) | 2004-04-20 | 2011-05-24 | Novartis Ag | Ventilation systems and methods employing aerosol generators |
US7971588B2 (en) | 2000-05-05 | 2011-07-05 | Novartis Ag | Methods and systems for operating an aerosol generator |
US20110171312A1 (en) * | 2008-09-19 | 2011-07-14 | Nektar Therapeutics | Modified therapeutic peptides, methods of their preparation and use |
WO2011163518A1 (en) | 2010-06-24 | 2011-12-29 | Gilead Sciences, Inc. | Pyrazolo [1, 5 -a] pyrimidines as antiviral agents |
WO2012012776A1 (en) | 2010-07-22 | 2012-01-26 | Gilead Sciences, Inc. | Methods and compounds for treating paramyxoviridae virus infections |
WO2012037038A1 (en) | 2010-09-13 | 2012-03-22 | Gilead Sciences, Inc. | 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment |
WO2012106382A1 (en) | 2011-01-31 | 2012-08-09 | Genoa Pharmaceuticals, Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
US8336545B2 (en) | 2000-05-05 | 2012-12-25 | Novartis Pharma Ag | Methods and systems for operating an aerosol generator |
US8357696B2 (en) | 2005-05-18 | 2013-01-22 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
WO2013016787A1 (en) | 2011-08-04 | 2013-02-07 | Victor Esteve | Powder inhaler |
EP2594272A2 (en) | 2005-05-18 | 2013-05-22 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US8561609B2 (en) | 2010-12-07 | 2013-10-22 | Respira Therapeutics, Inc. | Dry powder inhaler |
WO2013158776A1 (en) | 2012-04-17 | 2013-10-24 | Gilead Sciences, Inc. | Compounds and methods for antiviral treatment |
US20130327327A1 (en) * | 2012-06-06 | 2013-12-12 | Aerodesigns, Inc. | Aerosol dispenser with replaceable cartridge |
US8616195B2 (en) | 2003-07-18 | 2013-12-31 | Novartis Ag | Nebuliser for the production of aerosolized medication |
US8623817B2 (en) | 2008-08-11 | 2014-01-07 | Mannkind Corporation | Method of treating diabetes type 2 by administering ultrarapid acting insulin |
US8629139B2 (en) | 2008-10-07 | 2014-01-14 | Mpex Pharmaceuticals, Inc. | Topical use of Levofloxacin for reducing lung inflammation |
US8664187B2 (en) | 2004-06-18 | 2014-03-04 | Novartis Ag | Methods of treatment of endobronchial infections |
US8673360B2 (en) | 2004-08-10 | 2014-03-18 | Shin Nippon Biomedical Laboratories, Ltd. | Compositions that enable rapid-acting and highly absorptive intranasal administration |
US8683995B2 (en) | 2007-05-16 | 2014-04-01 | Mystic Pharmaceuticals, Inc. | Dose dispensing containers |
US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
US8815838B2 (en) | 2008-10-07 | 2014-08-26 | David C. Griffith | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
US8869794B1 (en) * | 2003-04-09 | 2014-10-28 | Novartis Pharma Ag | Aerosolization apparatus with capsule puncturing member |
WO2015006838A1 (en) | 2013-07-16 | 2015-01-22 | Victor Esteve | Powder inhaler |
USRE45404E1 (en) | 2003-03-27 | 2015-03-03 | Shin Nippon Biomedical Laboratories, Ltd. | Powder medicine applicator for nasal cavity |
US9060927B2 (en) | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake |
US9108211B2 (en) | 2005-05-25 | 2015-08-18 | Nektar Therapeutics | Vibration systems and methods |
US9138410B2 (en) | 2003-02-21 | 2015-09-22 | Shin Nippon Biomedical Laboratories, Ltd. | Compositions for nasal administration of pharmaceuticals |
US9192675B2 (en) | 2008-06-13 | 2015-11-24 | Mankind Corporation | Dry powder inhaler and system for drug delivery |
US9220687B2 (en) | 2008-12-29 | 2015-12-29 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9233159B2 (en) | 2011-10-24 | 2016-01-12 | Mannkind Corporation | Methods and compositions for treating pain |
US9241903B2 (en) | 2006-02-22 | 2016-01-26 | Mannkind Corporation | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
USD748242S1 (en) | 2014-07-11 | 2016-01-26 | H. Stuart Campbell | Inhaler mouthpiece |
US9248076B2 (en) | 2007-05-16 | 2016-02-02 | Mystic Pharmaceuticals, Inc. | Dose dispensing containers |
WO2016018697A1 (en) | 2014-07-28 | 2016-02-04 | Gilead Sciences, Inc. | Thieno [3,2-d] pyrimidine, furo [3,2,d] pyrimidine, and pyrrolo [3,2-d] pyrimidines useful for treating respiratory syncitial virus infections |
US9283193B2 (en) | 2005-09-14 | 2016-03-15 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
USD752204S1 (en) | 2014-03-10 | 2016-03-22 | Civitas Therapeutics, Inc. | Indicator for an inhaler |
USD752734S1 (en) | 2014-03-10 | 2016-03-29 | Civitas Therapeutics, Inc. | Inhaler grip |
US20160095989A1 (en) * | 2004-09-15 | 2016-04-07 | Optinose As | Nasal delivery devices |
USD755367S1 (en) | 2014-03-10 | 2016-05-03 | Civitas Therapeutics, Inc. | Indicator for an inhaler |
US9346766B2 (en) | 2004-08-20 | 2016-05-24 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
US9364436B2 (en) | 2011-06-17 | 2016-06-14 | Mannkind Corporation | High capacity diketopiperazine microparticles and methods |
US9492625B2 (en) | 2009-11-12 | 2016-11-15 | Stc.Unm | Dry powder inhaler with flutter dispersion member |
US20170006917A1 (en) * | 2015-07-07 | 2017-01-12 | Altria Client Services Inc. | E-vapor device including capsule containing pre-vapor formulation |
US9550036B2 (en) | 2011-03-03 | 2017-01-24 | Impel Neuropharma Inc. | Nasal drug delivery device |
US9630930B2 (en) | 2009-06-12 | 2017-04-25 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
US9662461B2 (en) | 2008-06-13 | 2017-05-30 | Mannkind Corporation | Dry powder drug delivery system and methods |
WO2017094027A1 (en) * | 2015-12-01 | 2017-06-08 | Cipla Limited | Nasal spray assembly |
US9675674B2 (en) | 2004-08-23 | 2017-06-13 | Mannkind Corporation | Diketopiperazine salts for drug delivery and related methods |
US9682153B2 (en) | 2008-09-19 | 2017-06-20 | Nektar Therapeutics | Polymer conjugates of therapeutic peptides |
US9700690B2 (en) | 2002-03-20 | 2017-07-11 | Mannkind Corporation | Inhalation apparatus |
US9700564B2 (en) | 2009-09-04 | 2017-07-11 | Horizon Orphan Llc | Use of aerosolized levofloxacin for treating cystic fibrosis |
US9706944B2 (en) | 2009-11-03 | 2017-07-18 | Mannkind Corporation | Apparatus and method for simulating inhalation efforts |
EP3210993A1 (en) | 2012-03-13 | 2017-08-30 | Gilead Sciences, Inc. | 2'- substituted carba-nucleoside analogs for antiviral treatment |
US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
US9802012B2 (en) | 2012-07-12 | 2017-10-31 | Mannkind Corporation | Dry powder drug delivery system and methods |
US9919117B2 (en) | 2011-05-09 | 2018-03-20 | Impel Neuropharma Inc. | Nozzles for nasal drug delivery |
US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
US9983108B2 (en) | 2009-03-11 | 2018-05-29 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
US9993488B2 (en) | 2014-02-20 | 2018-06-12 | Otitopic Inc. | Dry powder formulations for inhalation |
US10016582B2 (en) | 2008-02-07 | 2018-07-10 | University Of Washington Through Its Center For Commercialization | Circumferential aerosol device |
US10028966B2 (en) | 2014-01-10 | 2018-07-24 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
US10149823B2 (en) | 2013-04-30 | 2018-12-11 | Otitopic Inc. | Dry powder formulations and methods of use |
CN109078245A (en) * | 2018-10-11 | 2018-12-25 | 上海博极给药医药科技有限公司 | A kind of double-capsule type powder inhaler |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
US10195139B2 (en) | 2006-12-26 | 2019-02-05 | Shin Nippon Biomedical Laboratories, Ltd. | Preparation for transnasal application |
US10207065B2 (en) | 2013-07-12 | 2019-02-19 | John H. Silva | Mouthpiece for inhalers |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
EP3505173A1 (en) | 2013-11-11 | 2019-07-03 | Gilead Sciences, Inc. | Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections |
US10342938B2 (en) | 2008-06-13 | 2019-07-09 | Mannkind Corporation | Dry powder drug delivery system |
US10421729B2 (en) | 2013-03-15 | 2019-09-24 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
US10441733B2 (en) | 2012-06-25 | 2019-10-15 | Respira Therapeutics, Inc. | Powder dispersion devices and methods |
US10537692B2 (en) | 2013-04-28 | 2020-01-21 | Impel Neuropharma, Inc. | Medical unit dose container |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
US10625034B2 (en) | 2011-04-01 | 2020-04-21 | Mannkind Corporation | Blister package for pharmaceutical cartridges |
CN111372635A (en) * | 2017-11-21 | 2020-07-03 | 英倍尔药业股份有限公司 | Intranasal device with access port |
US20200289769A1 (en) * | 2017-10-12 | 2020-09-17 | Aptar France Sas | Device for dispensing a fluid product |
EP3738969A1 (en) | 2014-08-21 | 2020-11-18 | Gilead Sciences, Inc. | 2'-chloro aminopyrimidinone and pyrimidine dione nucleosides for use in treating pneumovirinae virus infections |
EP3782604A1 (en) | 2013-07-31 | 2021-02-24 | Windward Pharma, Inc. | Aerosol tyrosine kinase inhibitor compounds and uses thereof |
WO2021130638A1 (en) | 2019-12-24 | 2021-07-01 | Carna Biosciences, Inc. | Diacylglycerol kinase modulating compounds |
WO2021168038A1 (en) | 2020-02-18 | 2021-08-26 | Gilead Sciences, Inc. | Antiviral compounds |
WO2021168008A1 (en) | 2020-02-18 | 2021-08-26 | Gilead Sciences, Inc. | A 5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2-cyano-3,4-dihydroxytetrahydrofurane derivative as antiviral agent |
WO2021168004A1 (en) | 2020-02-18 | 2021-08-26 | Gilead Sciences, Inc. | Antiviral compounds |
WO2021167882A1 (en) | 2020-02-18 | 2021-08-26 | Gilead Sciences, Inc. | Antiviral compounds |
WO2021222522A1 (en) | 2020-05-01 | 2021-11-04 | Gilead Sciences, Inc. | Cd73 inhibiting 2,4-dioxopyrimidine compounds |
US11185497B2 (en) | 2018-01-05 | 2021-11-30 | Impel Neuropharma, Inc. | Intranasal delivery of dihydroergotamine by precision olfactory device |
US11266799B2 (en) | 2015-09-10 | 2022-03-08 | Impel Neuropharma, Inc. | In-line nasal delivery device |
US11273268B2 (en) * | 2016-07-07 | 2022-03-15 | Philip Morris Products S.A. | Nicotine inhaler system |
US11278492B2 (en) | 2018-01-05 | 2022-03-22 | Impel Neuropharma, Inc. | Intranasal delivery of olanzapine by precision olfactory device |
US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
US11471623B2 (en) | 2012-02-21 | 2022-10-18 | Respira Therapeutics, Inc. | Powder dispersion methods and devices |
WO2022240897A1 (en) | 2021-05-10 | 2022-11-17 | Sepelo Therapeutics, Llc | Pharmaceutical composition comprising delafloxacin for administration into the lung |
US11517548B2 (en) | 2018-07-19 | 2022-12-06 | Impel Pharmaceuticals Inc. | Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease |
WO2022271677A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
WO2022271659A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
WO2022271684A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
WO2022271650A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
US11571532B2 (en) | 2017-11-21 | 2023-02-07 | Impel Pharmaceuticals Inc. | Intranasal device with dip tube |
WO2023028364A1 (en) | 2021-08-27 | 2023-03-02 | Sepelo Therapeutics, Llc | Targeted compositions and uses therof |
WO2023077030A1 (en) | 2021-10-29 | 2023-05-04 | Gilead Sciences, Inc. | Cd73 compounds |
US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
US11759585B2 (en) | 2019-01-03 | 2023-09-19 | Impel Pharmaceuticals Inc. | Nasal drug delivery device with detachable nozzle |
US11878109B2 (en) | 2019-05-17 | 2024-01-23 | Impel Pharmaceuticals Inc. | Single-use nasal delivery device |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK198591D0 (en) * | 1991-12-10 | 1991-12-10 | Novo Nordisk As | APPARATUS |
DE19533979A1 (en) * | 1995-09-14 | 1997-03-20 | Alfred Von Schuckmann | Device for the dosed, airborne delivery of substances |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2307986A (en) * | 1940-02-15 | 1943-01-12 | Bolte | Insufflator |
US2517482A (en) * | 1949-04-09 | 1950-08-01 | Sharp & Dohme Inc | Inhaler |
US2519555A (en) * | 1945-08-31 | 1950-08-22 | Abbott Lab | Sterile medicament insufflator cartridge and insufflator |
US2581182A (en) * | 1950-03-14 | 1952-01-01 | Abbott Lab | Inhaler |
US2946332A (en) * | 1957-12-23 | 1960-07-26 | Nysco Lab Inc | Insufflator |
US3507277A (en) * | 1966-09-17 | 1970-04-21 | Fisons Pharmaceuticals Ltd | Inhalation device |
US3669113A (en) * | 1966-03-07 | 1972-06-13 | Fisons Ltd | Inhalation device |
-
1974
- 1974-03-29 FR FR7411171A patent/FR2224175B1/fr not_active Expired
- 1974-04-01 GB GB1440174A patent/GB1436813A/en not_active Expired
- 1974-04-01 BE BE142716A patent/BE813143A/en unknown
- 1974-04-02 US US457270A patent/US3906950A/en not_active Expired - Lifetime
- 1974-04-02 DE DE7411543U patent/DE7411543U/en not_active Expired
- 1974-04-02 DE DE2415961A patent/DE2415961A1/en active Pending
- 1974-04-03 CH CH465574A patent/CH569486A5/xx not_active IP Right Cessation
- 1974-04-03 JP JP49037060A patent/JPS5048782A/ja active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2307986A (en) * | 1940-02-15 | 1943-01-12 | Bolte | Insufflator |
US2519555A (en) * | 1945-08-31 | 1950-08-22 | Abbott Lab | Sterile medicament insufflator cartridge and insufflator |
US2517482A (en) * | 1949-04-09 | 1950-08-01 | Sharp & Dohme Inc | Inhaler |
US2581182A (en) * | 1950-03-14 | 1952-01-01 | Abbott Lab | Inhaler |
US2946332A (en) * | 1957-12-23 | 1960-07-26 | Nysco Lab Inc | Insufflator |
US3669113A (en) * | 1966-03-07 | 1972-06-13 | Fisons Ltd | Inhalation device |
US3507277A (en) * | 1966-09-17 | 1970-04-21 | Fisons Pharmaceuticals Ltd | Inhalation device |
Cited By (356)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4069819A (en) * | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
US4013075A (en) * | 1974-07-15 | 1977-03-22 | I.S.F. S.P.A. | Inhalers and insufflators having a cutting means |
US4240418A (en) * | 1974-08-22 | 1980-12-23 | Schering Aktiengesellschaft | Apparatus for the inhalation of medicinal agents |
US4105027A (en) * | 1975-06-13 | 1978-08-08 | Syntex Puerto Rico, Inc. | Inhalation device |
US4116195A (en) * | 1976-02-10 | 1978-09-26 | Allen & Hanburys Limited | Device for dispensing medicaments |
US4095596A (en) * | 1976-11-26 | 1978-06-20 | Smithkline Corporation | Nasal inhaler |
US4338931A (en) * | 1979-04-27 | 1982-07-13 | Claudio Cavazza | Device for the quick inhalation of drugs in powder form by humans suffering from asthma |
US4446862A (en) * | 1979-10-30 | 1984-05-08 | Baum Eric A | Breath actuated devices for administering powdered medicaments |
US4889114A (en) * | 1983-12-17 | 1989-12-26 | Boehringer Ingelheim Kg | Powdered pharmaceutical inhaler |
US4620847A (en) * | 1984-06-01 | 1986-11-04 | Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov | Device for administering powdered substances |
US4645487A (en) * | 1984-06-05 | 1987-02-24 | Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov | Device for administering powdered substances |
US4884565A (en) * | 1987-08-17 | 1989-12-05 | Miat S.P.A. | Insufflator for the administration of drugs in the form of a powder pre-dosed into opercola |
AU602603B2 (en) * | 1987-08-17 | 1990-10-18 | Miat S.P.A. | Insufflator for the administration of drugs in the form of a powder pre-dosed into opercola |
US5152284A (en) * | 1989-02-23 | 1992-10-06 | Phidea S.P.A. | Disposable inhaler with pre-pierced capsule |
US6048857A (en) * | 1989-10-17 | 2000-04-11 | Ellinwood, Jr.; Everett H. | Dosing method of administering medicaments via inhalation administration |
US5033463A (en) * | 1989-10-27 | 1991-07-23 | Miat S.P.A. | Multi-dose inhaler for medicaments in powder form |
US5617845A (en) * | 1990-08-30 | 1997-04-08 | Boehringer Ingelheim Kg | Inhalation device free from propellent gas |
US7040549B2 (en) | 1991-04-24 | 2006-05-09 | Aerogen, Inc. | Systems and methods for controlling fluid feed to an aerosol generator |
US7628339B2 (en) | 1991-04-24 | 2009-12-08 | Novartis Pharma Ag | Systems and methods for controlling fluid feed to an aerosol generator |
US5161524A (en) * | 1991-08-02 | 1992-11-10 | Glaxo Inc. | Dosage inhalator with air flow velocity regulating means |
US5366122A (en) * | 1991-08-27 | 1994-11-22 | Ing. Erich Pfeiffer Gmbh & Co. Kg | Dispenser for flowable media |
US5460173A (en) * | 1993-03-03 | 1995-10-24 | Tenax Corporation | Dry powder inhaler medicament carrier |
US5388572A (en) * | 1993-10-26 | 1995-02-14 | Tenax Corporation (A Connecticut Corp.) | Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same |
US5388573A (en) * | 1993-12-02 | 1995-02-14 | Tenax Corporation | Dry powder inhalator medicament carrier |
US5653191A (en) * | 1994-03-01 | 1997-08-05 | Calhoun; Clifford A. | Pressure indicator |
US5488946A (en) * | 1994-03-01 | 1996-02-06 | Calhoun; Clifford A. | Emergency breathing device for opening cartridges |
US5715811A (en) * | 1994-05-26 | 1998-02-10 | Unisia Jecs Corporation | Inhaling type medicine administering device and using method therefor |
WO1996012513A1 (en) * | 1994-10-24 | 1996-05-02 | Oxford Biosciences Limited | Particle delivery |
US5901703A (en) * | 1995-02-06 | 1999-05-11 | Unisia Jecs Corporation | Medicine administering device for nasal cavities |
EP0761248A1 (en) * | 1995-03-10 | 1997-03-12 | Unisia Jecs Corporation | Intranasal medicator |
US5921236A (en) * | 1995-03-10 | 1999-07-13 | Unisia Jecs Corporation | Medicine administering device for nasal cavities |
EP0761248A4 (en) * | 1995-03-10 | 1998-12-23 | Unisia Jecs Corp | Intranasal medicator |
US7174888B2 (en) | 1995-04-05 | 2007-02-13 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US20070209659A1 (en) * | 1995-04-05 | 2007-09-13 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US8561604B2 (en) | 1995-04-05 | 2013-10-22 | Novartis Ag | Liquid dispensing apparatus and methods |
US20040096403A1 (en) * | 1995-05-15 | 2004-05-20 | Mannkind Corporation | Method for drug delivery to the pulmonary system |
US8394414B2 (en) | 1995-05-15 | 2013-03-12 | Mannkind Corporation | Method for drug delivery to the pulmonary system |
US5988163A (en) * | 1995-08-02 | 1999-11-23 | Innovative Devices | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament |
US6209538B1 (en) * | 1995-08-02 | 2001-04-03 | Robert A. Casper | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
US5692496A (en) * | 1995-08-02 | 1997-12-02 | Innovative Devices, Llc | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
US5823183A (en) * | 1995-08-02 | 1998-10-20 | Innovative Devices | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
US6550477B1 (en) | 1995-08-02 | 2003-04-22 | Innovative Devices, Llc | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
US6561186B2 (en) | 1995-08-02 | 2003-05-13 | Innovative Devices | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
US5810004A (en) * | 1995-10-09 | 1998-09-22 | Unisia Jecs Corporation | Medicator for a capsule filled with a powdered drug |
US6013050A (en) * | 1995-10-20 | 2000-01-11 | Powderject Research Limited | Particle delivery |
US5752505A (en) * | 1996-03-21 | 1998-05-19 | Unisia Jecs Corporation | Inhalation-type medicine delivery device |
US6186141B1 (en) * | 1996-05-10 | 2001-02-13 | Glaxo Wellcome Inc. | Unit dose dispensing device |
WO1998058695A1 (en) * | 1997-06-23 | 1998-12-30 | Marco Cecchini | Inhaling device |
US6341605B1 (en) * | 1998-02-05 | 2002-01-29 | Unisia Jecs Corporation | Inhalant medicator |
US6273086B1 (en) * | 1998-02-06 | 2001-08-14 | Unisia Jecs Corporation | Inhalant medicator |
US20080230058A1 (en) * | 1998-06-04 | 2008-09-25 | Nektar Therapeutics | Dry powder dispersing apparatus and methods for their use |
US20030209243A1 (en) * | 1998-06-04 | 2003-11-13 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
US8161969B2 (en) | 1998-06-04 | 2012-04-24 | Novartis Ag | Dry powder dispersing apparatus and methods for their use |
US6546929B2 (en) | 1998-06-04 | 2003-04-15 | Inhale Therapeutic Systems, Inc. | Dry powder dispersing apparatus and methods for their use |
US6901929B2 (en) | 1998-06-04 | 2005-06-07 | Nektar Therapeutics | Dry powder dispersing apparatus and methods for their use |
US7422013B2 (en) | 1998-06-04 | 2008-09-09 | Nektar Therapeutics | Dry powder dispersing apparatus and methods for their use |
US7112341B1 (en) | 1999-04-13 | 2006-09-26 | Nektar Therapeutics | Pulmonary administration of dry powder formulations for treating infertility |
US9801925B2 (en) | 1999-06-29 | 2017-10-31 | Mannkind Corporation | Potentiation of glucose elimination |
US20110105391A1 (en) * | 1999-06-29 | 2011-05-05 | Mannkind Corporation | Methods and Compositions for Delivering Peptides |
US20100086609A1 (en) * | 1999-06-29 | 2010-04-08 | Mannkind Corporation | Methods and Compositions for Delivering Peptides |
US20070020191A1 (en) * | 1999-06-29 | 2007-01-25 | Mannkind Corporation | Potentiation of glucose elimination |
US8889099B2 (en) | 1999-06-29 | 2014-11-18 | Mannkind Corporation | Methods and compositions for delivering peptides |
US7648960B2 (en) | 1999-06-29 | 2010-01-19 | Mannkind Corporation | Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
US7943178B2 (en) | 1999-06-29 | 2011-05-17 | Mannkind Corporation | Methods and compositions for delivering peptides |
US8389470B2 (en) | 1999-06-29 | 2013-03-05 | Mannkind Corporation | Methods and compositions for delivering peptides |
US20040077528A1 (en) * | 1999-06-29 | 2004-04-22 | Mannkind Corporation | Purification and stabilization of peptide and protein pharmaceutical agents |
US8215300B2 (en) | 1999-07-23 | 2012-07-10 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US7464706B2 (en) | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US20080053437A1 (en) * | 1999-07-23 | 2008-03-06 | Mannkind Corporation | Unit dose capsules and dry powder inhaler |
US9061111B2 (en) | 1999-07-23 | 2015-06-23 | Mannkind Corporation | Unit dose capsules and dry powder inhaler |
US8671937B2 (en) | 1999-07-23 | 2014-03-18 | Mannkind Corporation | Unit dose capsules and dry powder inhaler |
US8950397B2 (en) | 1999-07-23 | 2015-02-10 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US20080190425A1 (en) * | 1999-07-23 | 2008-08-14 | Steiner Solomon S | Unit dose cartridge and dry powder inhaler |
US20040182387A1 (en) * | 1999-07-23 | 2004-09-23 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US8156936B2 (en) | 1999-07-23 | 2012-04-17 | Mannkind Corporation | Unit dose capsules and dry powder inhaler |
US20070023547A1 (en) * | 1999-09-09 | 2007-02-01 | Aerogen, Inc. | Aperture plate and methods for its construction and use |
US8398001B2 (en) | 1999-09-09 | 2013-03-19 | Novartis Ag | Aperture plate and methods for its construction and use |
US7066398B2 (en) | 1999-09-09 | 2006-06-27 | Aerogen, Inc. | Aperture plate and methods for its construction and use |
US8501240B2 (en) | 1999-10-29 | 2013-08-06 | Novartis Ag | Compositions comprising an active agent |
US20090117193A1 (en) * | 1999-10-29 | 2009-05-07 | Nektar Therapeutics | Compositions Comprising an Active Agent |
EP1108439A3 (en) * | 1999-12-15 | 2003-09-10 | Ing. Erich Pfeiffer GmbH | Product dispenser |
US20010029947A1 (en) * | 1999-12-17 | 2001-10-18 | Steve Paboojian | Receptacles to facilitate the extraction of powders |
US7331339B2 (en) | 2000-05-05 | 2008-02-19 | Aerogen, Inc. | Methods and systems for operating an aerosol generator |
US7748377B2 (en) | 2000-05-05 | 2010-07-06 | Novartis Ag | Methods and systems for operating an aerosol generator |
US7322349B2 (en) | 2000-05-05 | 2008-01-29 | Aerogen, Inc. | Apparatus and methods for the delivery of medicaments to the respiratory system |
US7971588B2 (en) | 2000-05-05 | 2011-07-05 | Novartis Ag | Methods and systems for operating an aerosol generator |
US8336545B2 (en) | 2000-05-05 | 2012-12-25 | Novartis Pharma Ag | Methods and systems for operating an aerosol generator |
US20020134382A1 (en) * | 2000-05-10 | 2002-09-26 | Snow John M. | Medicament container with same side airflow inlet and outlet and method of use |
US7318436B2 (en) | 2000-05-10 | 2008-01-15 | Innovative Devices, Llc | Medicament container with same side airflow inlet and outlet and method of use |
US6948494B1 (en) | 2000-05-10 | 2005-09-27 | Innovative Devices, Llc. | Medicament container with same side airflow inlet and outlet and method of use |
US6923178B2 (en) | 2000-05-10 | 2005-08-02 | Innovative Devices, Llc. | Medicament container with same side airflow inlet and outlet |
US20050056281A1 (en) * | 2000-05-10 | 2005-03-17 | Snow John M. | Medicament container with same side airflow inlet and outlet and method of use |
US7032593B2 (en) | 2000-08-14 | 2006-04-25 | Advanced Inhalation Research, Inc. | Inhalation device and method |
US7100600B2 (en) * | 2001-03-20 | 2006-09-05 | Aerogen, Inc. | Fluid filled ampoules and methods for their use in aerosolizers |
US7195011B2 (en) | 2001-03-20 | 2007-03-27 | Aerogen, Inc. | Convertible fluid feed system with comformable reservoir and methods |
US7032590B2 (en) | 2001-03-20 | 2006-04-25 | Aerogen, Inc. | Fluid filled ampoules and methods for their use in aerosolizers |
US8196573B2 (en) | 2001-03-20 | 2012-06-12 | Novartis Ag | Methods and systems for operating an aerosol generator |
US7146978B2 (en) | 2001-04-16 | 2006-12-12 | Advanced Inhalation Research, Inc. | Inhalation device and method |
US7278425B2 (en) | 2001-04-16 | 2007-10-09 | Alkermes, Inc. | Inhalation device and method |
US20060283448A1 (en) * | 2001-04-16 | 2006-12-21 | Advanced Inhalation Research, Inc. | Inhalation device and method |
US6732732B2 (en) | 2001-04-16 | 2004-05-11 | Advanced Inhalation Research, Inc. | Inhalation device and method |
US20040154619A1 (en) * | 2001-04-16 | 2004-08-12 | Advanced Inhalation Research, Inc. | Inhalation device and method |
US20040154618A1 (en) * | 2001-04-16 | 2004-08-12 | Advanced Inhalation Research, Inc. | Inhalation device and method |
US20040216738A1 (en) * | 2001-04-16 | 2004-11-04 | Advanced Inhalation Research, Inc. | Inhalation device and method |
US6978941B2 (en) | 2001-05-02 | 2005-12-27 | Aerogen, Inc. | Base isolated nebulizing device and methods |
US7104463B2 (en) | 2001-05-02 | 2006-09-12 | Aerogen, Inc. | Base isolated nebulizing device and methods |
US6681768B2 (en) | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
US7163013B2 (en) * | 2001-10-05 | 2007-01-16 | Alchemy Healthcare Limited | Apparatus for the nasal or oral delivery of a medicament |
US20050028813A1 (en) * | 2001-10-05 | 2005-02-10 | Ian Harrison | Apparatus for the nasal or oral delivery of a medicament |
US7600511B2 (en) | 2001-11-01 | 2009-10-13 | Novartis Pharma Ag | Apparatus and methods for delivery of medicament to a respiratory system |
US20030150454A1 (en) * | 2001-11-14 | 2003-08-14 | Inhale Therapeutic Systems, Inc. | Aerosolization apparatus with removable mouthpiece |
US10124128B2 (en) * | 2001-11-14 | 2018-11-13 | Bgp Products Operations Gmbh | Aerosolization apparatus with removable mouthpiece |
US20080063606A1 (en) * | 2001-12-19 | 2008-03-13 | Tarara Thomas E | Pulmonary delivery of aminoglycoside |
US9421166B2 (en) | 2001-12-19 | 2016-08-23 | Novartis Ag | Pulmonary delivery of aminoglycoside |
US8715623B2 (en) | 2001-12-19 | 2014-05-06 | Novartis Ag | Pulmonary delivery of aminoglycoside |
US7677467B2 (en) | 2002-01-07 | 2010-03-16 | Novartis Pharma Ag | Methods and devices for aerosolizing medicament |
US7360536B2 (en) | 2002-01-07 | 2008-04-22 | Aerogen, Inc. | Devices and methods for nebulizing fluids for inhalation |
US8539944B2 (en) | 2002-01-07 | 2013-09-24 | Novartis Ag | Devices and methods for nebulizing fluids for inhalation |
US20030131847A1 (en) * | 2002-01-16 | 2003-07-17 | Fabrizio Niccolai | Device usable in the treatment of affections of the airways |
US6705313B2 (en) * | 2002-01-16 | 2004-03-16 | Ph&T S.P.A. | Device usable in the treatment of affections of the airways |
US9700690B2 (en) | 2002-03-20 | 2017-07-11 | Mannkind Corporation | Inhalation apparatus |
US7353823B2 (en) * | 2002-05-14 | 2008-04-08 | Bioactis Limited | Powder chemical feeding device for nasal cavity |
US20050177095A1 (en) * | 2002-05-14 | 2005-08-11 | Tatsuo Tsutsui | Powder chemical feeding device for nasal cavity |
US7771642B2 (en) | 2002-05-20 | 2010-08-10 | Novartis Ag | Methods of making an apparatus for providing aerosol for medical treatment |
US20040206350A1 (en) * | 2002-12-19 | 2004-10-21 | Nektar Therapeutics | Aerosolization apparatus with non-circular aerosolization chamber |
US9138410B2 (en) | 2003-02-21 | 2015-09-22 | Shin Nippon Biomedical Laboratories, Ltd. | Compositions for nasal administration of pharmaceuticals |
USRE45404E1 (en) | 2003-03-27 | 2015-03-03 | Shin Nippon Biomedical Laboratories, Ltd. | Powder medicine applicator for nasal cavity |
US20090260623A1 (en) * | 2003-04-09 | 2009-10-22 | Novartis Pharma Ag | Aeorosolization apparatus with air inlet shield |
USRE47526E1 (en) | 2003-04-09 | 2019-07-23 | BGP Products | Aerosolization apparatus with air inlet shield |
US8069851B2 (en) | 2003-04-09 | 2011-12-06 | Novartis Ag | Aeorosolization apparatus with air inlet shield |
US7559325B2 (en) | 2003-04-09 | 2009-07-14 | Novartis Pharma Ag | Aerosolization apparatus with air inlet shield |
US8869794B1 (en) * | 2003-04-09 | 2014-10-28 | Novartis Pharma Ag | Aerosolization apparatus with capsule puncturing member |
US20050150492A1 (en) * | 2003-04-09 | 2005-07-14 | Nektar Therapeutics | Aerosolization apparatus with air inlet shield |
US8616195B2 (en) | 2003-07-18 | 2013-12-31 | Novartis Ag | Nebuliser for the production of aerosolized medication |
US20050088617A1 (en) * | 2003-10-27 | 2005-04-28 | Jen-Chuen Hsieh | Method and apparatus for visual drive control |
US20050153874A1 (en) * | 2004-01-12 | 2005-07-14 | Mannkind Corporation | Method of reducing serum proinsulin levels in type 2 diabetics |
US20050186146A1 (en) * | 2004-02-12 | 2005-08-25 | Nektar Therapeutics | Interleukin-13 antagonist powders, spray-dried particles, and methods |
US8933023B2 (en) | 2004-03-12 | 2015-01-13 | Biodel Inc. | Rapid acting injectable insulin compositions |
US20090192075A1 (en) * | 2004-03-12 | 2009-07-30 | Biodel Inc. | Amylin Formulations |
US20080090753A1 (en) * | 2004-03-12 | 2008-04-17 | Biodel, Inc. | Rapid Acting Injectable Insulin Compositions |
US7201167B2 (en) | 2004-04-20 | 2007-04-10 | Aerogen, Inc. | Method and composition for the treatment of lung surfactant deficiency or dysfunction |
US7946291B2 (en) | 2004-04-20 | 2011-05-24 | Novartis Ag | Ventilation systems and methods employing aerosol generators |
US7290541B2 (en) | 2004-04-20 | 2007-11-06 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
US7267121B2 (en) | 2004-04-20 | 2007-09-11 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
US20070051362A1 (en) * | 2004-04-23 | 2007-03-08 | Sullivan Timothy R | Multiple unit dose drug delivery system |
US20050255119A1 (en) * | 2004-05-10 | 2005-11-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives |
US7727962B2 (en) | 2004-05-10 | 2010-06-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder comprising new compositions of oligosaccharides and methods for their preparation |
US7723306B2 (en) | 2004-05-10 | 2010-05-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation |
US7611709B2 (en) | 2004-05-10 | 2009-11-03 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives |
US20050250704A1 (en) * | 2004-05-10 | 2005-11-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder comprising new compositions of oligosaccharides and methods for their preparation |
US20050250705A1 (en) * | 2004-05-10 | 2005-11-10 | Boehringer Ingelheim Pharma Gmbh Co. Kg | Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation |
US8664187B2 (en) | 2004-06-18 | 2014-03-04 | Novartis Ag | Methods of treatment of endobronchial infections |
US8673360B2 (en) | 2004-08-10 | 2014-03-18 | Shin Nippon Biomedical Laboratories, Ltd. | Compositions that enable rapid-acting and highly absorptive intranasal administration |
US9346766B2 (en) | 2004-08-20 | 2016-05-24 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
US9796688B2 (en) | 2004-08-20 | 2017-10-24 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
US9675674B2 (en) | 2004-08-23 | 2017-06-13 | Mannkind Corporation | Diketopiperazine salts for drug delivery and related methods |
US10130685B2 (en) | 2004-08-23 | 2018-11-20 | Mannkind Corporation | Diketopiperazine salts for drug delivery and related methods |
US20160095989A1 (en) * | 2004-09-15 | 2016-04-07 | Optinose As | Nasal delivery devices |
US10398859B2 (en) * | 2004-09-15 | 2019-09-03 | Optinose As | Nasal delivery devices |
WO2006051300A1 (en) | 2004-11-10 | 2006-05-18 | Cipla Limited | Inhaler |
US8006695B2 (en) | 2004-11-10 | 2011-08-30 | Cipla Limited | Inhaler |
US20080105256A1 (en) * | 2004-11-10 | 2008-05-08 | Cipla Limited | Inhaler |
US20110183901A1 (en) * | 2005-03-31 | 2011-07-28 | Mannkind Corporation | Superior Control of Blood Glucose in Diabetes Treatment |
EP2594272A2 (en) | 2005-05-18 | 2013-05-22 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US20090090433A1 (en) * | 2005-05-18 | 2009-04-09 | Symyx Technologies Europe Sa | Apparatus And Method For Storing And Dispensing Material, Especially In Micro Quantities And In Combination With Limited Starting Amounts |
US8357696B2 (en) | 2005-05-18 | 2013-01-22 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US8524735B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US10987357B2 (en) | 2005-05-18 | 2021-04-27 | Horizon Orphan, LLC | Aerosolized fluoroquinolones and uses thereof |
US8524734B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US8546423B2 (en) | 2005-05-18 | 2013-10-01 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US9108211B2 (en) | 2005-05-25 | 2015-08-18 | Nektar Therapeutics | Vibration systems and methods |
US9717689B2 (en) | 2005-09-14 | 2017-08-01 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
US10143655B2 (en) | 2005-09-14 | 2018-12-04 | Mannkind Corporation | Method of drug formulation |
US9283193B2 (en) | 2005-09-14 | 2016-03-15 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
US9446001B2 (en) | 2005-09-14 | 2016-09-20 | Mannkind Corporation | Increasing drug affinity for crystalline microparticle surfaces |
US20090137455A1 (en) * | 2005-09-29 | 2009-05-28 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
US8084420B2 (en) | 2005-09-29 | 2011-12-27 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
US20070086952A1 (en) * | 2005-09-29 | 2007-04-19 | Biodel, Inc. | Rapid Acting and Prolonged Acting Inhalable Insulin Preparations |
US10130581B2 (en) | 2006-02-22 | 2018-11-20 | Mannkind Corporation | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
US9241903B2 (en) | 2006-02-22 | 2016-01-26 | Mannkind Corporation | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
AU2007219498B2 (en) * | 2006-02-24 | 2013-08-22 | Esteve, Victor | Dry powder inhaler |
KR101150000B1 (en) | 2006-02-24 | 2012-06-01 | 아하 쿤스트스트오프테크니크 게엠베하 | Dry powder inhaler |
US8539946B2 (en) | 2006-02-24 | 2013-09-24 | Eric Zembrod | Dry powder inhaler |
CN101389367B (en) * | 2006-02-24 | 2011-10-05 | 阿哈塑料技术有限公司 | Dry powder inhaler |
WO2007098870A1 (en) * | 2006-02-24 | 2007-09-07 | Aha Kunststofftechnik Gmbh | Dry powder inhaler |
US20110120463A1 (en) * | 2006-02-24 | 2011-05-26 | Victor Esteve | Dry powder inhaler |
US7713929B2 (en) | 2006-04-12 | 2010-05-11 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
US20080039368A1 (en) * | 2006-04-12 | 2008-02-14 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
US7718609B2 (en) | 2006-04-12 | 2010-05-18 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
US8584669B2 (en) | 2006-04-13 | 2013-11-19 | Boehringer Ingelheim International Gmbh | Inhaler |
US20090194105A1 (en) * | 2006-04-13 | 2009-08-06 | Jens Besseler | Inhaler |
US20070283955A1 (en) * | 2006-06-07 | 2007-12-13 | Bioactis Limites | Peroral powder delivery device |
US7806117B2 (en) * | 2006-06-07 | 2010-10-05 | Shin Nippon Biomedical Laboratories, Ltd. | Peroral powder delivery device |
US20090320838A1 (en) * | 2006-06-16 | 2009-12-31 | Cipla Limited | Dry powder inhaler |
US8522775B2 (en) * | 2006-06-16 | 2013-09-03 | Cipla Limited | Dry powder inhaler |
US10195139B2 (en) | 2006-12-26 | 2019-02-05 | Shin Nippon Biomedical Laboratories, Ltd. | Preparation for transnasal application |
US8377009B2 (en) | 2007-01-09 | 2013-02-19 | Mystic Pharmaceuticals, Inc. | Intranasal cartridge devices |
US20080177246A1 (en) * | 2007-01-09 | 2008-07-24 | First City Tower | Intranasal Cartridge Devices |
US20080248999A1 (en) * | 2007-04-04 | 2008-10-09 | Biodel Inc. | Amylin formulations |
US8875704B2 (en) | 2007-04-05 | 2014-11-04 | Optinose As | Nasal administration |
US10722667B2 (en) | 2007-04-05 | 2020-07-28 | Optinose As | Nasal administration |
US20100288275A1 (en) * | 2007-04-05 | 2010-11-18 | Optinose As | Nasal administration |
US9649456B2 (en) * | 2007-04-05 | 2017-05-16 | Optinose As | Nasal administration |
US8683995B2 (en) | 2007-05-16 | 2014-04-01 | Mystic Pharmaceuticals, Inc. | Dose dispensing containers |
US7669597B2 (en) | 2007-05-16 | 2010-03-02 | Mystic Pharmaceuticals, Inc. | Combination unit dose dispensing containers |
US9592354B2 (en) | 2007-05-16 | 2017-03-14 | Mystic Pharmaceuticals, Inc. | Combination unit dose dispensing containers |
US9248076B2 (en) | 2007-05-16 | 2016-02-02 | Mystic Pharmaceuticals, Inc. | Dose dispensing containers |
US20090025721A1 (en) * | 2007-06-12 | 2009-01-29 | Alkermes, Inc. | Powder inhaler devices |
US8496002B2 (en) | 2007-06-12 | 2013-07-30 | Civitas Therapeutics, Inc. | Powder inhaler devices |
US8919342B2 (en) | 2007-08-01 | 2014-12-30 | Boehringer Ingelheim International Gmbh | Inhaler |
US20100313886A1 (en) * | 2007-08-01 | 2010-12-16 | Herbert Wachtel | Inhaler |
CN101815552B (en) * | 2007-08-01 | 2013-03-06 | 贝林格尔.英格海姆国际有限公司 | Inhaler |
US7963089B2 (en) | 2007-09-14 | 2011-06-21 | Mystic Pharmaceuticals, Inc. | Deep draw container forming method |
US20090071108A1 (en) * | 2007-09-14 | 2009-03-19 | Mystic Pharmaceuticals, Inc. | Deep draw container forming method |
US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
US20100287884A1 (en) * | 2007-10-25 | 2010-11-18 | Sangita Seshadri | Powder conditioning of unit dose drug packages |
US20090175840A1 (en) * | 2008-01-04 | 2009-07-09 | Biodel, Inc. | Insulin formulations for insulin release as a function of tissue glucose levels |
US9125998B2 (en) | 2008-01-24 | 2015-09-08 | Vectura Delivery Devices Limited | Inhaler |
US20110056488A1 (en) * | 2008-01-24 | 2011-03-10 | Vectura Delivery Devices Limited | Inhaler |
US10016582B2 (en) | 2008-02-07 | 2018-07-10 | University Of Washington Through Its Center For Commercialization | Circumferential aerosol device |
US20090241949A1 (en) * | 2008-03-27 | 2009-10-01 | Smutney Chad C | Dry powder inhalation system |
US10342938B2 (en) | 2008-06-13 | 2019-07-09 | Mannkind Corporation | Dry powder drug delivery system |
US10751488B2 (en) | 2008-06-13 | 2020-08-25 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US9511198B2 (en) | 2008-06-13 | 2016-12-06 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US9339615B2 (en) | 2008-06-13 | 2016-05-17 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US10201672B2 (en) | 2008-06-13 | 2019-02-12 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US9662461B2 (en) | 2008-06-13 | 2017-05-30 | Mannkind Corporation | Dry powder drug delivery system and methods |
US9192675B2 (en) | 2008-06-13 | 2015-11-24 | Mankind Corporation | Dry powder inhaler and system for drug delivery |
US9446133B2 (en) | 2008-06-13 | 2016-09-20 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US10675421B2 (en) | 2008-06-20 | 2020-06-09 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
US8623817B2 (en) | 2008-08-11 | 2014-01-07 | Mannkind Corporation | Method of treating diabetes type 2 by administering ultrarapid acting insulin |
US9943571B2 (en) | 2008-08-11 | 2018-04-17 | Mannkind Corporation | Use of ultrarapid acting insulin |
US9682153B2 (en) | 2008-09-19 | 2017-06-20 | Nektar Therapeutics | Polymer conjugates of therapeutic peptides |
US20110171312A1 (en) * | 2008-09-19 | 2011-07-14 | Nektar Therapeutics | Modified therapeutic peptides, methods of their preparation and use |
US9717738B2 (en) | 2008-10-07 | 2017-08-01 | Horizon Orphan Llc | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
US10149854B2 (en) | 2008-10-07 | 2018-12-11 | Horizon Orphan Llc | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
US9326936B2 (en) | 2008-10-07 | 2016-05-03 | Raptor Pharmaceuticals, Inc. | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
US8629139B2 (en) | 2008-10-07 | 2014-01-14 | Mpex Pharmaceuticals, Inc. | Topical use of Levofloxacin for reducing lung inflammation |
US10722519B2 (en) | 2008-10-07 | 2020-07-28 | Horizon Orphan Llc | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
US8815838B2 (en) | 2008-10-07 | 2014-08-26 | David C. Griffith | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
US11020481B2 (en) | 2008-10-07 | 2021-06-01 | Horizon Orphan Llc | Topical use of levofloxacin for reducing lung inflammation |
US10172850B2 (en) | 2008-12-29 | 2019-01-08 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9220687B2 (en) | 2008-12-29 | 2015-12-29 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9655850B2 (en) | 2008-12-29 | 2017-05-23 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9060927B2 (en) | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake |
US9983108B2 (en) | 2009-03-11 | 2018-05-29 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
US20110033544A1 (en) * | 2009-05-15 | 2011-02-10 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal pharmaceutical compositions with improved pharmacokinetcs |
US9101539B2 (en) | 2009-05-15 | 2015-08-11 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal pharmaceutical compositions with improved pharmacokinetics |
US9630930B2 (en) | 2009-06-12 | 2017-04-25 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
US8827946B2 (en) | 2009-07-31 | 2014-09-09 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
US20110045088A1 (en) * | 2009-07-31 | 2011-02-24 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
US9700564B2 (en) | 2009-09-04 | 2017-07-11 | Horizon Orphan Llc | Use of aerosolized levofloxacin for treating cystic fibrosis |
US10792289B2 (en) | 2009-09-04 | 2020-10-06 | Horizon Orphan Llc | Use of aerosolized levofloxacin for treating cystic fibrosis |
US10231975B2 (en) | 2009-09-04 | 2019-03-19 | Horizon Orphan Llc | Use of aerosolized levofloxacin for treating cystic fibrosis |
US9706944B2 (en) | 2009-11-03 | 2017-07-18 | Mannkind Corporation | Apparatus and method for simulating inhalation efforts |
US9492625B2 (en) | 2009-11-12 | 2016-11-15 | Stc.Unm | Dry powder inhaler with flutter dispersion member |
EP3012258A1 (en) | 2010-06-24 | 2016-04-27 | Gilead Sciences, Inc. | Pyrazolo[1,5-a]pyrimidines and -triazines as antiviral agents |
WO2011163518A1 (en) | 2010-06-24 | 2011-12-29 | Gilead Sciences, Inc. | Pyrazolo [1, 5 -a] pyrimidines as antiviral agents |
WO2012012776A1 (en) | 2010-07-22 | 2012-01-26 | Gilead Sciences, Inc. | Methods and compounds for treating paramyxoviridae virus infections |
WO2012037038A1 (en) | 2010-09-13 | 2012-03-22 | Gilead Sciences, Inc. | 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment |
US8651104B2 (en) | 2010-12-07 | 2014-02-18 | Respira Therapeutics, Inc. | Bead-containing dry powder inhaler |
US8561609B2 (en) | 2010-12-07 | 2013-10-22 | Respira Therapeutics, Inc. | Dry powder inhaler |
EP4059499A1 (en) | 2011-01-31 | 2022-09-21 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
WO2012106382A1 (en) | 2011-01-31 | 2012-08-09 | Genoa Pharmaceuticals, Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
US9550036B2 (en) | 2011-03-03 | 2017-01-24 | Impel Neuropharma Inc. | Nasal drug delivery device |
US11730903B2 (en) | 2011-03-03 | 2023-08-22 | Impel Pharmaceuticals Inc. | Nasal drug delivery device |
US10507295B2 (en) | 2011-03-03 | 2019-12-17 | Impel Neuropharma, Inc. | Nasal drug delivery device |
US10625034B2 (en) | 2011-04-01 | 2020-04-21 | Mannkind Corporation | Blister package for pharmaceutical cartridges |
US10940278B2 (en) | 2011-05-09 | 2021-03-09 | Impel Neuropharma, Inc. | Nozzles for nasal drug delivery |
US11890412B2 (en) | 2011-05-09 | 2024-02-06 | Impel Pharmaceuticals Inc. | Nozzles for nasal drug delivery |
US9919117B2 (en) | 2011-05-09 | 2018-03-20 | Impel Neuropharma Inc. | Nozzles for nasal drug delivery |
US11007332B2 (en) | 2011-05-09 | 2021-05-18 | Impel Neuropharma, Inc. | Nozzles for nasal drug delivery |
US9364436B2 (en) | 2011-06-17 | 2016-06-14 | Mannkind Corporation | High capacity diketopiperazine microparticles and methods |
US10130709B2 (en) | 2011-06-17 | 2018-11-20 | Mannkind Corporation | High capacity diketopiperazine microparticles and methods |
WO2013016787A1 (en) | 2011-08-04 | 2013-02-07 | Victor Esteve | Powder inhaler |
WO2013016784A1 (en) | 2011-08-04 | 2013-02-07 | Victor Esteve | Dry powder inhaler |
US10258664B2 (en) | 2011-10-24 | 2019-04-16 | Mannkind Corporation | Methods and compositions for treating pain |
US9233159B2 (en) | 2011-10-24 | 2016-01-12 | Mannkind Corporation | Methods and compositions for treating pain |
US9610351B2 (en) | 2011-10-24 | 2017-04-04 | Mannkind Corporation | Methods and compositions for treating pain |
US11471623B2 (en) | 2012-02-21 | 2022-10-18 | Respira Therapeutics, Inc. | Powder dispersion methods and devices |
EP3210993A1 (en) | 2012-03-13 | 2017-08-30 | Gilead Sciences, Inc. | 2'- substituted carba-nucleoside analogs for antiviral treatment |
EP3932931A1 (en) | 2012-03-13 | 2022-01-05 | Gilead Sciences, Inc. | A nebulizer comprising a pharmaceutical composition comprising 2'- substituted carba-nucleoside analogs for antiviral treatment |
MD4496C1 (en) * | 2012-03-13 | 2018-02-28 | Gilead Sciences, Inc. | 2'-Substituted carba-nucleoside analogs for antiviral treatment |
EP3351552A1 (en) | 2012-03-13 | 2018-07-25 | Gilead Sciences, Inc. | 2'- substituted carba-nucleoside analogs for antiviral treatment |
WO2013158776A1 (en) | 2012-04-17 | 2013-10-24 | Gilead Sciences, Inc. | Compounds and methods for antiviral treatment |
US20130327327A1 (en) * | 2012-06-06 | 2013-12-12 | Aerodesigns, Inc. | Aerosol dispenser with replaceable cartridge |
US9845187B2 (en) * | 2012-06-06 | 2017-12-19 | Aerodesigns, Inc. | Aerosol dispenser with replaceable cartridge |
US10441733B2 (en) | 2012-06-25 | 2019-10-15 | Respira Therapeutics, Inc. | Powder dispersion devices and methods |
US9802012B2 (en) | 2012-07-12 | 2017-10-31 | Mannkind Corporation | Dry powder drug delivery system and methods |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
US10421729B2 (en) | 2013-03-15 | 2019-09-24 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
US10537692B2 (en) | 2013-04-28 | 2020-01-21 | Impel Neuropharma, Inc. | Medical unit dose container |
US11191910B2 (en) | 2013-04-28 | 2021-12-07 | Impel Neuropharma, Inc. | Medical unit dose container |
US11865210B2 (en) | 2013-04-30 | 2024-01-09 | Vectura Inc. | Dry powder formulations and methods of use |
US10149823B2 (en) | 2013-04-30 | 2018-12-11 | Otitopic Inc. | Dry powder formulations and methods of use |
US11819569B2 (en) | 2013-04-30 | 2023-11-21 | Vectura Inc. | Treating inflammation with inhaled aspirin |
US10207065B2 (en) | 2013-07-12 | 2019-02-19 | John H. Silva | Mouthpiece for inhalers |
WO2015006838A1 (en) | 2013-07-16 | 2015-01-22 | Victor Esteve | Powder inhaler |
US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
EP3782604A1 (en) | 2013-07-31 | 2021-02-24 | Windward Pharma, Inc. | Aerosol tyrosine kinase inhibitor compounds and uses thereof |
US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
EP3505173A1 (en) | 2013-11-11 | 2019-07-03 | Gilead Sciences, Inc. | Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections |
EP4122932A1 (en) | 2013-11-11 | 2023-01-25 | Gilead Sciences, Inc. | Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections |
US10028966B2 (en) | 2014-01-10 | 2018-07-24 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
US9993488B2 (en) | 2014-02-20 | 2018-06-12 | Otitopic Inc. | Dry powder formulations for inhalation |
USD755367S1 (en) | 2014-03-10 | 2016-05-03 | Civitas Therapeutics, Inc. | Indicator for an inhaler |
USD752734S1 (en) | 2014-03-10 | 2016-03-29 | Civitas Therapeutics, Inc. | Inhaler grip |
USD752204S1 (en) | 2014-03-10 | 2016-03-22 | Civitas Therapeutics, Inc. | Indicator for an inhaler |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
USD748242S1 (en) | 2014-07-11 | 2016-01-26 | H. Stuart Campbell | Inhaler mouthpiece |
WO2016018697A1 (en) | 2014-07-28 | 2016-02-04 | Gilead Sciences, Inc. | Thieno [3,2-d] pyrimidine, furo [3,2,d] pyrimidine, and pyrrolo [3,2-d] pyrimidines useful for treating respiratory syncitial virus infections |
EP4023650A1 (en) | 2014-07-28 | 2022-07-06 | Gilead Sciences, Inc. | 4'-substituted-furo[3,2-d]pyrimidine and -pyrrolo[3,2- d]pyrimidine derivatives useful for treating respiratory syncitial virus infections |
EP3693367A1 (en) | 2014-07-28 | 2020-08-12 | Gilead Sciences, Inc. | Thieno [3,2-d]pyrimidines, furo [3,2,d]pyrimidines and pyrrolo [3,2-d]pyrimidines useful for treating respiratory syncitial virus infections |
EP3738969A1 (en) | 2014-08-21 | 2020-11-18 | Gilead Sciences, Inc. | 2'-chloro aminopyrimidinone and pyrimidine dione nucleosides for use in treating pneumovirinae virus infections |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
US10874139B2 (en) * | 2015-07-07 | 2020-12-29 | Altria Client Services Llc | E-vapor device including capsule containing pre-vapor formulation |
US20170006917A1 (en) * | 2015-07-07 | 2017-01-12 | Altria Client Services Inc. | E-vapor device including capsule containing pre-vapor formulation |
US11266799B2 (en) | 2015-09-10 | 2022-03-08 | Impel Neuropharma, Inc. | In-line nasal delivery device |
WO2017094027A1 (en) * | 2015-12-01 | 2017-06-08 | Cipla Limited | Nasal spray assembly |
US10940274B2 (en) | 2015-12-01 | 2021-03-09 | Cipla Limited | Nasal spray assembly |
US11273268B2 (en) * | 2016-07-07 | 2022-03-15 | Philip Morris Products S.A. | Nicotine inhaler system |
US12102754B2 (en) | 2017-09-26 | 2024-10-01 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
US11672926B2 (en) * | 2017-10-12 | 2023-06-13 | Aptar France Sas | Device for dispensing a fluid product |
US20200289769A1 (en) * | 2017-10-12 | 2020-09-17 | Aptar France Sas | Device for dispensing a fluid product |
CN111372635B (en) * | 2017-11-21 | 2022-08-16 | 英倍尔制药公司 | Intranasal device with access port |
US11878110B2 (en) | 2017-11-21 | 2024-01-23 | Impel Pharmaceuticals Inc. | Intranasal device with inlet interface |
US11571532B2 (en) | 2017-11-21 | 2023-02-07 | Impel Pharmaceuticals Inc. | Intranasal device with dip tube |
US11395887B2 (en) | 2017-11-21 | 2022-07-26 | Impel Pharmaceuticals Inc. | Intranasal device with inlet interface |
CN111372635A (en) * | 2017-11-21 | 2020-07-03 | 英倍尔药业股份有限公司 | Intranasal device with access port |
US11185497B2 (en) | 2018-01-05 | 2021-11-30 | Impel Neuropharma, Inc. | Intranasal delivery of dihydroergotamine by precision olfactory device |
US11752100B2 (en) | 2018-01-05 | 2023-09-12 | Impel Pharmaceuticals Inc. | Intranasal delivery of olanzapine by precision olfactory device |
US11278492B2 (en) | 2018-01-05 | 2022-03-22 | Impel Neuropharma, Inc. | Intranasal delivery of olanzapine by precision olfactory device |
US11517548B2 (en) | 2018-07-19 | 2022-12-06 | Impel Pharmaceuticals Inc. | Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease |
US11690819B2 (en) | 2018-07-19 | 2023-07-04 | Impel Pharmaceuticals Inc. | Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's disease |
CN109078245A (en) * | 2018-10-11 | 2018-12-25 | 上海博极给药医药科技有限公司 | A kind of double-capsule type powder inhaler |
US11759585B2 (en) | 2019-01-03 | 2023-09-19 | Impel Pharmaceuticals Inc. | Nasal drug delivery device with detachable nozzle |
US11878109B2 (en) | 2019-05-17 | 2024-01-23 | Impel Pharmaceuticals Inc. | Single-use nasal delivery device |
WO2021130638A1 (en) | 2019-12-24 | 2021-07-01 | Carna Biosciences, Inc. | Diacylglycerol kinase modulating compounds |
EP4445902A2 (en) | 2019-12-24 | 2024-10-16 | Carna Biosciences, Inc. | Diacylglycerol kinase modulating compounds |
WO2021168004A1 (en) | 2020-02-18 | 2021-08-26 | Gilead Sciences, Inc. | Antiviral compounds |
WO2021168038A1 (en) | 2020-02-18 | 2021-08-26 | Gilead Sciences, Inc. | Antiviral compounds |
WO2021168008A1 (en) | 2020-02-18 | 2021-08-26 | Gilead Sciences, Inc. | A 5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2-cyano-3,4-dihydroxytetrahydrofurane derivative as antiviral agent |
WO2021167882A1 (en) | 2020-02-18 | 2021-08-26 | Gilead Sciences, Inc. | Antiviral compounds |
WO2021222522A1 (en) | 2020-05-01 | 2021-11-04 | Gilead Sciences, Inc. | Cd73 inhibiting 2,4-dioxopyrimidine compounds |
WO2022240897A1 (en) | 2021-05-10 | 2022-11-17 | Sepelo Therapeutics, Llc | Pharmaceutical composition comprising delafloxacin for administration into the lung |
WO2022271650A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
WO2022271684A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
WO2022271659A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
WO2022271677A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
WO2023028364A1 (en) | 2021-08-27 | 2023-03-02 | Sepelo Therapeutics, Llc | Targeted compositions and uses therof |
WO2023077030A1 (en) | 2021-10-29 | 2023-05-04 | Gilead Sciences, Inc. | Cd73 compounds |
Also Published As
Publication number | Publication date |
---|---|
DE7411543U (en) | 1976-02-05 |
DE2415961A1 (en) | 1974-10-17 |
CH569486A5 (en) | 1975-11-28 |
BE813143A (en) | 1974-07-31 |
JPS5048782A (en) | 1975-05-01 |
FR2224175A1 (en) | 1974-10-31 |
FR2224175B1 (en) | 1978-04-14 |
GB1436813A (en) | 1976-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3906950A (en) | Inhaling device for powdered medicaments | |
US3949751A (en) | Method and device for dispensing medicament to the body | |
US1848711A (en) | Hypodermic sybinckb | |
US4295828A (en) | Ejector holder for syringe-type cartridge | |
AU627795B2 (en) | Syringe guide with a device for adjusting the depth of penetration of the needle into the skin | |
US5102393A (en) | Autoinjector converted from intramuscular to subcutaneous mode of injection | |
ES2288870T3 (en) | RETRACTILE DENTAL SYRINGE. | |
JP2728141B2 (en) | Disposable needle-free injection device | |
TWI288649B (en) | Powdery medicine dispensing device for nasal cavity | |
AU726983B2 (en) | Syringe with retractable needle assembly | |
US8708973B2 (en) | Medicament delivery device powered by volute spring | |
US3757781A (en) | Tool for administering pills to animals | |
US3080866A (en) | Hypodermic needle | |
US3724460A (en) | Disposable cartridge for admixing two components of injectable medicament | |
US20030093032A1 (en) | Intradermal delivery device and method | |
US3046985A (en) | Dental syringe adapter | |
CA2891102A1 (en) | Fluid delivery device and method | |
AR043668A1 (en) | SPRING RETAINING FOR SYRINGE | |
JPS6034385B2 (en) | Arrow needle intradermal piercing device | |
GB1558985A (en) | Inhalation devices | |
AU7263487A (en) | Mixing and discharge capsule | |
US3182660A (en) | Hypodermic syringe with spring biassed piston | |
US3066671A (en) | Disposable additive container | |
US2688967A (en) | Metal aspirating syringe | |
CN112236239B (en) | Applicator |